Malte Leithäuser

High-dose methotrexate with or without whole brain radiotherapy for primary CNS lymphoma (G-PCNSL-SG-1): a phase 3, randomised, non-inferiority trial

Eckhard Thiel, Agnieszka Korfel, Peter Martus et al. · The Lancet Oncology · 2010 · 622 citations

Medicine, Oncology, Pharmacotherapy +10

Sequential treatment with rituximab followed by CHOP chemotherapy in adult B-cell post-transplant lymphoproliferative disorder (PTLD): the prospective international multicentre phase 2 PTLD-1 trial

Ralf Ulrich Trappe, Stephan Oertel, Véronique Leblond et al. · The Lancet Oncology · 2011 · 386 citations

Medicine, Immunology, Oncology +9

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial

Agnieszka Korfel, Michael Weller, Peter Martus et al. · Annals of Oncology · 2012 · 67 citations

Medicine, Neurology, Oncology +10

International Prognostic Index, Type of Transplant and Response to Rituximab Are Key Parameters to Tailor Treatment in Adults With CD20-Positive B Cell PTLD: Clues From the PTLD-1 Trial

Ralf Ulrich Trappe, Sylvain Choquet, Daan Dierickx et al. · American Journal of Transplantation · 2015 · 56 citations · Full text

Life Sciences, Immunology, Pharmacotherapy +16

Rapid and sustained clearance of circulating lymphoma cells after chemotherapy plus rituximab: clinical significance of quantitative t(14;18) PCR monitoring in advanced stage follicular lymphoma patients^†

Carsten Hirt, Frank Schüler, Thomas Kiefer et al. · British Journal of Haematology · 2008 · 43 citations · Full text

Medicine, Hematology, Oncology +13